Bussel JB - Search Results

1

What is the best second-line treatment for immune thrombocytopenia?

Mahévas M, Bussel JB. Mahévas M, et al. Among authors: bussel jb. Br J Haematol. 2024 Oct;205(4):1267-1268. doi: 10.1111/bjh.19777. Br J Haematol. 2024. PMID: 39415321

2

The fetal and neonatal consequences of maternal alloimmune thrombocytopenia.

Bussel J, Kaplan C. Bussel J, et al. Baillieres Clin Haematol. 1998 Jun;11(2):391-408. doi: 10.1016/s0950-3536(98)80057-7. Baillieres Clin Haematol. 1998. PMID: 10097816 Review.

3

A dose of 75 microg/kg/d of i.v. anti-D increases the platelet count more rapidly and for a longer period of time than 50 microg/kg/d in adults with immune thrombocytopenic purpura.

Newman GC, Novoa MV, Fodero EM, Lesser ML, Woloski BM, Bussel JB. Newman GC, et al. Among authors: bussel jb. Br J Haematol. 2001 Mar;112(4):1076-8. doi: 10.1046/j.1365-2141.2001.02627.x. Br J Haematol. 2001. PMID: 11298610 Free article. Clinical Trial.

4

Intravenous anti-D as a treatment for immune thrombocytopenic purpura (ITP) during pregnancy.

Michel M, Novoa MV, Bussel JB. Michel M, et al. Among authors: bussel jb. Br J Haematol. 2003 Oct;123(1):142-6. doi: 10.1046/j.1365-2141.2003.04567.x. Br J Haematol. 2003. PMID: 14510957 Free article.

5

Intravenous (IV) anti-D and IV immunoglobulin achieve acute platelet increases by different mechanisms: modulation of cytokine and platelet responses to IV anti-D by FcgammaRIIa and FcgammaRIIIa polymorphisms.

Cooper N, Heddle NM, Haas M, Reid ME, Lesser ML, Fleit HB, Woloski BM, Bussel JB. Cooper N, et al. Among authors: bussel jb. Br J Haematol. 2004 Feb;124(4):511-8. doi: 10.1111/j.1365-2141.2004.04804.x. Br J Haematol. 2004. PMID: 14984503 Free article.

6

The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura.

Cooper N, Stasi R, Cunningham-Rundles S, Feuerstein MA, Leonard JP, Amadori S, Bussel JB. Cooper N, et al. Among authors: bussel jb. Br J Haematol. 2004 Apr;125(2):232-9. doi: 10.1111/j.1365-2141.2004.04889.x. Br J Haematol. 2004. PMID: 15059147 Free article.

7

The pathogenesis of immune thrombocytopaenic purpura.

Cooper N, Bussel J. Cooper N, et al. Br J Haematol. 2006 May;133(4):364-74. doi: 10.1111/j.1365-2141.2006.06024.x. Br J Haematol. 2006. PMID: 16643442 Free article. Review.

8

Treatment of immune thrombocytopenic purpura in adults.

Bussel J. Bussel J. Semin Hematol. 2006 Jul;43(3 Suppl 5):S3-10; discussion S18-9. doi: 10.1053/j.seminhematol.2006.04.009. Semin Hematol. 2006. PMID: 16815346 Review.

9

The immune thrombocytopenic purpura (ITP) bleeding score: assessment of bleeding in patients with ITP.

Page LK, Psaila B, Provan D, Michael Hamilton J, Jenkins JM, Elish AS, Lesser ML, Bussel JB. Page LK, et al. Among authors: bussel jb. Br J Haematol. 2007 Jul;138(2):245-8. doi: 10.1111/j.1365-2141.2007.06635.x. Epub 2007 Jun 3. Br J Haematol. 2007. PMID: 17542983 Free article.

10

The effect of anti-CD40 ligand in immune thrombocytopenic purpura.

Patel VL, Schwartz J, Bussel JB. Patel VL, et al. Among authors: bussel jb. Br J Haematol. 2008 May;141(4):545-8. doi: 10.1111/j.1365-2141.2008.07039.x. Epub 2008 Mar 12. Br J Haematol. 2008. PMID: 18341638 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

369 results

Search Page

Filters